Live from CDMO Live Europe 2026 in Rotterdam 🇳🇱 Cenexi is pleased to be on site until tomorrow alongside key players from the global biopharma outsourcing community. This event is a great opportunity to engage in strategic discussions around the future of pharmaceutical development and manufacturing, while connecting with partners across the industry. At Cenexi, we support pharma and biotech companies with: - Sterile expertise (vials, lyophilised products, prefilled syringes) - Tech transfer & industrialisation capabilities - End-to-end CDMO solutions for complex products 🤝 Attending CDMO Live Europe? Let’s connect in Rotterdam and discuss your upcoming projects with David Gaubert, our Business Development Manager. #CDMOLiveEurope #CDMO #Pharma #Biotech #Sterile #TechTransfer #Manufacturing #Partnership
Cenexi
Fabrication de produits pharmaceutiques
Creating innovative partnerships | CDMO
À propos
Depuis 2004, date de sa création, Cenexi est un sous-traitant de l’industrie pharmaceutique spécialisé dans la formulation, le développement, la fabrication et le remplissage de produits pharmaceutiques (CDMO). Le Groupe se positionne sur le marché international très actif du médicament à indication thérapeutique majeure, en s’appuyant sur son esprit d’innovation et son expertise. Il compte parmi les leaders européens dans la fabrication de produits stériles et injectables (70 % de son chiffre d’affaires actuel, 80 % projeté d’ici 3 ans), avec une proportion croissante de produits biologiques. Avec ses quatre sites de production (Fontenay-sous-Bois, Hérouville-Saint-Clair et Osny en France, Braine-l'Alleud en Belgique) et ses 1 400 collaborateurs, son CA en 2023 s’est élevé à 191 millions d’euros.
- Site web
-
http://www.cenexi.com
Lien externe pour Cenexi
- Secteur
- Fabrication de produits pharmaceutiques
- Taille de l’entreprise
- 1 001-5 000 employés
- Siège social
- Fontenay-sous-bois
- Type
- Société civile/Société commerciale/Autres types de sociétés
- Fondée en
- 2004
Lieux
Employés chez Cenexi
Nouvelles
-
Cenexi is attending CDMO Live Europe 2026 📅 19–21 May 📍 Rotterdam We’re pleased to join CDMO Live Europe, a key event bringing together the global biopharma outsourcing community to connect, share insights and engage in strategic discussions shaping the future of pharma development and manufacturing. At Cenexi, we support our partners with end-to-end CDMO solutions, combining: • Sterile expertise (vials, lyophilised products, prefilled syringes) • Biologics & complex modalities • Tech transfer and industrialisation capabilities 🤝 Attending CDMO Live? Let’s connect in Rotterdam with David Gaubert, our Business Development Manager and explore how we can support your next development or manufacturing project. #CDMOLive #CDMO #Pharma #Biotech #Outsourcing #Sterile #TechTransfer #Manufacturing #Partnership
-
-
Cenexi is attending Swiss Biotech Day 2026 🇨🇭 We’re pleased to join one of Europe’s leading biotech events, bringing together innovators, industry leaders and investors from across the life sciences ecosystem. Our Business Developer Paloma Gomez will be on site to connect with biotech and pharma partners and discuss how Cenexi supports the development and manufacturing of complex therapies. As a trusted CDMO partner, we provide end-to-end solutions, with strong expertise in: • Sterile drug products (vials, lyophilised products, prefilled syringes) • Biologics, including mAbs and ADCs • High-potent compounds 🤝 Attending Swiss Biotech Day? Let’s connect with Paloma Gomez and explore how we can support your next development or manufacturing project. #SwissBiotechDay #Biotech #CDMO #Pharma #Biologics #Sterile #Innovation #Partnership
-
-
🗽Thank you from Manhattan, New York! This week, Cenexi had the pleasure of spending a busy and inspiring week in Manhattan, New York, meeting with clients and prospects from across the pharmaceutical industry. Alain Kirchmeyer, CEO of Cenexi, and Christine ADAM-PERCHEC, Head of Business Development, were delighted to connect in person, discuss ongoing projects, explore new opportunities, and strengthen relationships with our partners. These moments are key to building strong collaborations and supporting our clients in the development and manufacturing of their injectable drugs. Thank you to everyone who took the time to meet with us during this great New York week — we look forward to continuing our discussions and building future successes together. #Cenexi #CDMO #Injectables #PharmaceuticalIndustry #BusinessDevelopment #NewYork #Partnership #Pharma
-
-
Cenexi is heading to BIO-Europe Spring 2026 in Lisbon 🇵🇹 📅 23–25 March Our Business Developer Paloma Gomez will be on site representing Cenexi at BIO-Europe Spring, and connecting with industry peers, biotech innovators, potential partners and clients throughout the event. 🤝 We’re excited to explore new collaboration opportunities, discussing emerging trends, and exploring how Cenexi can support your pharmaceutical and biotech projects. Attending BIO-Europe Spring? Let’s connect and schedule a meeting with Paloma Gomez #BIOEuropeSpring #Lisbon #CDMO #Biotech #Pharma #Partnership
-
-
[🔴 LIVE] Cenexi is at Pharmapack in Paris — yesterday and today (January 21–22) ! Our Sourcing & Purchasing team is attending this key industry event dedicated to pharmaceutical manufacturers, with a strong focus on sterile injectables. Throughout the event, our teams are meeting with strategic suppliers, exploring the latest innovations and trends in injectable drug packaging, and strengthening long-term partnerships - all with one goal in mind: anticipating tomorrow’s solutions for our customers. 🤝 We would also be delighted to meet our clients during the event to discuss their upcoming projects and specific needs. #CDMO #Pharma #Pharmapack #PharmaPackaging #SterileInjectables #SupplyChain #Sourcing #Partnership #Innovation
-
-
Nous recrutons (#hiring) pour le poste de PHARMACIEN RESPONSABLE / DIRECTEUR QUALITÉ (H/F (Fontenay-sous-Bois, Île-de-France). Postulez dès maintenant ou partagez ce post avec votre réseau.
-
🎆 Cenexi wishes you all the best for 2026! A new year, new opportunities: welcome to 2026. As we step into this new year, Cenexi remains fully committed to supporting pharmaceutical and biotech partners with reliable, compliant and high-quality CDMO solutions. Building on the momentum of 2025, marked by innovation, knowledge sharing, international events and strong human connections, our teams are ready to: - further develop our expertise in sterile injectables and complex dosage forms; - strengthen partnerships across the pharmaceutical ecosystem; continue investing in people, skills and talent development; - and contribute every day, to advancing healthcare worldwide. ✨ We wish you a successful, inspiring and collaborative year ahead. Let’s make 2026 a year of progress, trust and shared success. #HappyNewYear #Pharma #CDMO #Innovation #Healthcare #Partnerships #Expertise #SterileInjectable
-
-
🎄 Cenexi teams wish you a happy holiday season! As the year draws to a close, we would like to take a moment to thank you. 2025 has been a year marked by strong collaboration, meaningful exchanges, and shared achievements between Cenexi and its clients. Throughout the year, together with our partners and customers, we have: 1. engaged in high-value discussions with clients and industry leaders at major pharmaceutical events across Europe and beyond; 2. co-developed and strengthened expertise in sterile injectable manufacturing and lyophilisation, supporting our clients’ products and pipelines; 3. jointly invested in training, safety, and continuous improvement initiatives, including Lean Six Sigma programs, to enhance reliability and performance; 4. and, above all, worked side by side every day toward a shared objective: delivering high-quality pharmaceutical manufacturing in support of patients worldwide. ✨ To our clients, partners, colleagues, and future collaborators, thank you for your trust, collaboration, and long-term commitment. #Pharma #CDMO #EndOfYear #Partnerships #TeamSpirit #Healthcare #Expertise #SterileInjectable
-
-
🌟 Thank you for CPHI Frankfurt 2025 – A milestone in our journey! As CPHI Frankfurt 2025 comes to a close, we extend our heartfelt thanks to everyone who visited Cenexi at Hall 3.1 – Booth D6 and engaged with our team over these three dynamic days. ✅ This event reaffirmed our mission: to enable pharma and biotech partners with our proven sterile-products expertise — from oncology injectables to hormonal and desensitiser dosage forms. With our production footprint in France & Belgium and mastery of high-potent manufacturing, we stand ready to turn complex drug-product goals into reality. We’re excited about the next steps and the collaborations sparked here in Frankfurt. See you next year! #CPHI2025 #Frankfurt #CDMO #Pharma #Sterile #Aseptic #Biological #Hormones #HighPotent #TechTransfer #Manufacturing #Quality #Regulatory